Comparison of in vitro hepatic models for the prediction of metabolic interaction between simvastatin and naringenin
β Scribed by N. Le Goff; J. C. Koffel; S. Vandenschrieck; L. Jung; G. Ubeaud
- Publisher
- Springer-Verlag
- Year
- 2002
- Tongue
- English
- Weight
- 980 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0378-7966
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The potential for various natural products to perturb the metabolism and disposition of medications has been recognized for decades. There are numerous __in vitro__ and __in vivo__ methods available to screen botanical products for drug interaction potential. Although many normal volunt
Because of the importance of complement activation in the induced activation of leukocytes in vivo, determination of the complement-activating capacity of a candidate biomaterial is an important step in evaluating its biocompatibility. In vitro evaluation can be performed in the presence of human se
Although displacement from plasma protein binding (dPB) is usually of little clinical significance, it should be taken into account when interpreting changes in total plasma concentrations of drugs subject to metabolically based drug-drug interactions (mDDI). The aim of this study was to develop an